Existing risk factors fail to explain the increased frequency of cardiovascular disease in people with type 2 diabetes. The identification of new vasculopathic biomarkers in early glucose disorders may assist our understanding of the disease and its complications. Emerging functional and structural biomarkers have the potential to revolutionize current approaches to the prevention, treatment, and risk stratification of vascular disease. We invite articles which utilize well-validated surrogates of endothelial dysfunction, arterial stiffness, and inflammation in diabetes, impaired glucose tolerance, or impaired fasting glycaemia. Cross-sectional prospective or even interventional designs with biomarker outcomes would be considered. Of particular interest are interracial comparisons underpinning theories of cardiometabolic disease susceptibility in Asians and Afro-Caribbeans. Potential topics include, but are not limited to:

• Candidate markers of hemodynamic/endothelial function associating with or predicting vascular complications in impaired glucose regulation
• Putative mechanisms of premature conduit vessel sclerosis in diabetes and implications for future biomarker development
• Epidemiological inflammatory biomarker studies within ethnic groups at risk of cardiometabolic disease

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jdr/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable: